Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Neoplasms 2Stroke 1Recurrence 1Ovarian Neoplasms 1Neurologic Manifestations 1Melanoma 1Margins of Excision 1Malignant Solid Neoplasm 1Malignant Female Reproductive System Neoplasm 1Inflammatory Breast Neoplasms 1Glioblastoma 1Fallopian Tube Neoplasms 1Communication 1Colorectal Neoplasms 1Caregiver Burden 1Carcinoma, Ovarian Epithelial 1Breast Neoplasms 1Brain Neoplasms 1Brain Injuries, Traumatic 1Brain Injuries 1Advanced Malignant Solid Neoplasm 1

Interventions

Letrozole 25Fulvestrant 25Specimen Handling 19ribociclib 16Capecitabine 16pembrolizumab 14palbociclib 14Paclitaxel 14Trastuzumab 13Carboplatin 13exemestane 12abemaciclib 12Tamoxifen 12Anastrozole 12Magnetic Resonance Spectroscopy 11trastuzumab deruxtecan 8pertuzumab 8Biopsy 8Goserelin 7inavolisib 6giredestrant 6Cyclophosphamide 6130-nm albumin-bound paclitaxel 6patritumab deruxtecan 5eribulin 5elacestrant 5Taxes 5Standard of Care 5Radiotherapy 5Gonadotropin-Releasing Hormone 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Breast Neoplasms × Palliative Care × 30 days × Clear all
NCT07474090 2026-06-01

STEPS-BC

Wake Forest University Health Sciences

Phase NA Active not recruiting
120 enrolled
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡